BRIDGEWATER, New Jersey and BENGALURU, Karnataka, India, April 10, 2025 — Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), today announced that the U.S. Food and Drug Administration (U.S. FDA) has approved…Original Article
FDA Approves Jobevne (bevacizumab-nwgd), a Biosimilar to Avastin
